Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to pricing of prescription drugs.
Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Duration: March 6, 2012
to
December 31, 2019
General Issues: Pharmacy , Taxation/Internal Revenue Code , Medicare/Medicaid , Copyright/Patent/Trademark , Trade (Domestic & Foreign) , Telecommunications
Spending: about $510,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2012: House of Representatives, U.S. Senate, House of Representatives,, Office of the Vice President of the United States, White House Office
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Julian A. Haywood StaffDir/Counsel,HouseOversight&GovtReformSubcommittee
Minority Counsel,HouseOversight&GovtReformCommittee
Counsel, House Committee on Standards of Official Conduct
Legislative Assistant & Counsel, Rep. Steny Hoyer
Legislative Assistant, Rep. Julian Dixon
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2019
FORGE Federal Affairs LLC terminated an engagement in which they represented Lilly USA LLC on April 14, 2020.
Original Filing: 301166086.xml
Lobbying Issues
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to pricing of prescription drugs.
Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Jan. 19, 2020.
Original Filing: 301121768.xml
Lobbying Issues
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to pricing of prescription drugs.
Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068952.xml
Lobbying Issues
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to pricing of prescription drugs.
Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on July 18, 2019.
Original Filing: 301050011.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on April 22, 2019.
Original Filing: 301037299.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Jan. 20, 2019.
Original Filing: 301010997.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987882.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on July 20, 2018.
Original Filing: 300975919.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on April 19, 2018.
Original Filing: 300951733.xml
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation and cuts to Medicare Part D funding; H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123).
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Jan. 19, 2018.
Original Filing: 300928252.xml
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform;
H.R.1, Tax Cuts and Jobs Act (P.L.115-97).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Oct. 13, 2017.
Original Filing: 300903850.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and health care reform proposals.
H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to reauthorization of the Prescription Drug User Fee Act.
P.L.115-52, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on July 19, 2017.
Original Filing: 300889057.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and health care reform proposals.
H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Issues related to reauthorization of the Prescription Drug User Fee Act.
H.R.2430/S.934, FDA Reauthorization Act of 2017.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on April 20, 2017.
Original Filing: 300871931.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and health care reform proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs. Opposition to prescription drug importation. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to reauthorization of the Prescription Drug User Fee Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Jan. 19, 2017.
Original Filing: 300851812.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and funding measures.
Issues related to CMS initiative on Medicare Part B Drug Payment Model.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act.
Issues related to patent reform.
Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Issues related to IP protections for pharmaceuticals and biologics in Trans Pacific Partnership trade agreement.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Oct. 20, 2016.
Original Filing: 300836856.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and funding measures.
Issues related to CMS initiative on Medicare Part B Drug Payment Model.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act.
Issues related to patent reform.
Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Issues related to IP protections for pharmaceuticals and biologics in Trans Pacific Partnership trade agreement.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on July 19, 2016.
Original Filing: 300815349.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and funding measures.
Issues related to CMS initiative on Medicare Part B Drug Payment Model.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act.
Issues related to patent reform.
Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Issues related to IP protections for pharmaceuticals and biologics in Trans Pacific Partnership trade agreement.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on April 20, 2016.
Original Filing: 300801686.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and funding measures.
Issues related to CMS initiative on Medicare Part B Drug Payment Model.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act.
Issues related to patent reform.
Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Issues related to IP protections for pharmaceuticals and biologics in Trans Pacific Partnership trade agreement.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to pricing of prescription drugs.
Opposition to prescription drug importation.
Support for funding of Department of Homeland Security drug interdiction efforts.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2015
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Jan. 17, 2016.
Original Filing: 300773648.xml
Lobbying Issues
Issues related to Medicare Part D reform proposals in budget and funding measures.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore revenue and corporate tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2015
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on Oct. 17, 2015.
Original Filing: 300755974.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2015
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on July 20, 2015.
Original Filing: 300741497.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2015
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $20,000. The report was filed on April 15, 2015.
Original Filing: 300715877.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for Dormant Therapies Act in 21st Century Cures discussion draft.
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2014
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Jan. 20, 2015.
Original Filing: 300702893.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for Modern Cures Act (H.R. 3116).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
3rd Quarter, 2014
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Oct. 20, 2014.
Original Filing: 300682758.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for Modern Cures Act (H.R. 3116).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
2nd Quarter, 2014
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on July 17, 2014.
Original Filing: 300658768.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for Modern Cures Act (H.R. 3116).
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
1st Quarter, 2014
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on April 21, 2014.
Original Filing: 300647634.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for Modern Cures Act (H.R. 3116).
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issue involving invalidation of U.S. pharmaceutical company patents by Canadian judiciary.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
4th Quarter, 2013
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Jan. 21, 2014.
Original Filing: 300625290.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
3rd Quarter, 2013
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Oct. 18, 2013.
Original Filing: 300598691.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Encourage congressional support for Medicare coverage of amyloid imaging brain scans for diagnosis of early Alzheimer's.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
2nd Quarter, 2013
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on July 18, 2013.
Original Filing: 300575091.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
1st Quarter, 2013
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on April 15, 2013.
Original Filing: 300550452.xml
Lobbying Issues
Issues related to Medicare Part D Drug Rebate proposal in budget proposals.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitored issues related to taxation of offshore entities and corporate tax reform.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitored issues related to S. 21 Cybersecurity Act of 2013 and Executive Order on cybersecurity.
4th Quarter, 2012
FORGE Federal Affairs LLC amended a lobbying report for representation of Lilly USA LLC in Q42012 on April 15, 2013.
Original Filing: 300550450.xml
Lobbying Issues
Issues related to Medicare Part D in the Fiscal Cliff legislation, American Taxpayers Relief Act (H.R.8).
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to the taxation of offshore entities.
Issues related to H.R.8, American Taxpayer Relief Act of 2012 (Fiscal Cliff legislation).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to S.2105, Cybersecurity Act of 2012.
4th Quarter, 2012
In Q4, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Jan. 19, 2013.
Original Filing: 300536008.xml
Lobbying Issues
Issues related to Medicare Part D in the Fiscal Cliff legislation, American Taxpayers Relief Act (H.R.8).
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to the taxation of offshore entities.
Issues related to H.R.8, American Taxpayer Relief Act of 2012 (Fiscal Cliff legislation).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2012
In Q3, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508569.xml
Lobbying Issues
Issues related to Prescription Drug User Fee Act (PDUFA).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to the taxation of offshore entities.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Medicare Part D.
2nd Quarter, 2012
In Q2, FORGE Federal Affairs LLC lobbied for Lilly USA LLC , earning $10,000. The report was filed on July 18, 2012.
Original Filing: 300488160.xml
Lobbying Issues
Issues related to Prescription Drug User Fee Act (PDUFA).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to the taxation of offshore entities.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Medicare Part D.
1st Quarter, 2012
In Q1, FORGE Federal Affairs LLC lobbied for Lilly USA LLC . The report was filed on April 16, 2012.
Original Filing: 300460788.xml
Lobbying Issues
Issues related to Prescription Drug User Fee Act (PDUFA).
Lobbying Issues
Issues related to patent/IP protections for biotech and pharmaceutical drugs.
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Issues related to the taxation of offshore entities.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to Medicare Part D.
1st Quarter, 2012
FORGE Federal Affairs LLC filed a lobbying registration on March 25, 2012 to represent Lilly USA LLC, effective March 6, 2012.
Original Filing: 300456883.xml
Issue(s) they said they’d lobby about: Issues related to prescription drug user fee act (PDUFA), taxation of offshore entities, patent/IP protections for biotech and pharmaceutical drugs, Medicare Part D. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...